Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death.
about
Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survivalRisk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia.A genetic marker within the CD44 gene confirms linkage at 11p13 in African-American families with lupus stratified by thrombocytopenia, but genetic association with CD44 is not present.Familiality and co-occurrence of clinical features of systemic lupus erythematosus.Systemic lupus erythematosus in 50 year olds.Outcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus.Outcome of patients with systemic lupus erythematosus in intensive care unit.Review of ACR hematologic criteria in systemic lupus erythematosus.Functional promoter haplotypes of the human FAS gene are associated with the phenotype of SLE characterized by thrombocytopenia.Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus.Splenectomy for thrombocytopenia associated with systemic lupus erythematosus in 11 Chinese patients.Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis.Associations of serum urea, creatinine and uric acid with clinical and laboratory features in patients with systemic lupus erythematosus.Clinical implications and prognostic significance of thrombocytopenia in Tunisian patients with systemic lupus erythematosus.Clinical characteristics and risk factors of intracranial hemorrhage in systemic lupus erythematosus.Acute presentation of thrombocytopaenia in systemic lupus erythematosus is associated with a high mortality in South Africa.Clinical features and outcome of pregnancy with SLE-associated thrombocytopenia.Haematological manifestations of lupus.Predictors of arthritis in pediatric patients with lupusThrombocytopenia in Systemic Lupus Erythematosus: Clinical Manifestations, Treatment, and Prognosis in 230 Patients.Prognostic significance of platelet count in SLE patients.SLE mortality in an oriental population.Effect of extremely low dose cyclosporine treatment on the thrombocytopenia in systemic lupus erythematosus.Systemic lupus erythematosus VII: frequency and impact of secondary Sjøgren's syndrome.Scleroderma and survivalExpression of systemic lupus erythematosus in various ethnic Jewish Israeli groups.The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus.Understanding the epidemiology and progression of systemic lupus erythematosusChildhood-onset systemic lupus erythematosus: a comparative study of African Americans and Latin Americans.Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study.Epidemiology of cardiovascular disease in systemic lupus erythematosus.Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort.Racial disparities in age at time of cardiovascular events and cardiovascular-related death in patients with systemic lupus erythematosus.Combination therapy: the risks of infection and tumor induction.Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based studyEnd-stage renal disease due to lupus nephritis among children in the US, 1995-2006.Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox.Severity of systemic lupus erythematosus with diffuse proliferative glomerulonephritis and the ineffectiveness of standard pulse intravenous cyclophosphamide therapy in Jamaican patients.Increased risk of death in African American patients with end-stage renal disease secondary to lupus.
P2860
Q28607141-184718CA-31C8-494E-A7E6-0E04B206D147Q33341018-F06251A7-144D-492B-A26F-251DB9135B08Q33344045-E765B201-3322-4C02-900A-A313FEC97F8DQ33344131-B0F7B0D1-CB48-43C6-8B67-8C12E82090ACQ33344758-487DCB2D-FA32-4E55-A1EA-551E186C1CA9Q33356370-E42B2EB5-EB07-43F5-9D52-CAB13A1F9406Q33361803-14D0F1D2-AE20-470D-9996-FA70FA68B48FQ33362490-51A8F31E-FE0F-43E2-A3F7-0EEB3C599DBBQ33363999-2051AB1D-75F6-42C7-B15C-545FDE692ECEQ33368456-B66BA2CE-5570-4DF4-A5E5-A14F5487CE52Q33370573-18A85401-D6DE-42BD-B150-5EC9D354719BQ33386932-840B4F59-A112-4B70-9456-51D1A3698DA8Q33389368-05488D8A-BE6A-4821-9B80-77348DB2E025Q33396421-01963A5D-FBD9-4CAE-9B91-3016A0EEC507Q33399850-DAAA6873-2314-4B70-89BF-C1FD875DC7FDQ33406816-51FA534F-8FF1-47E9-9417-90A396960949Q33411369-3664F0A5-E8DE-444F-8AB1-2F6053F9631CQ33420949-708F4891-22E1-44CA-8F2C-89A46D0C419EQ33421876-33FB9F60-4018-48DA-8547-15017E7FCEB8Q33424360-5B8998FF-3BF2-4995-9E67-22184D14B9B9Q33429997-C44A87B8-7423-4F08-9F99-ADBDA6A82629Q33435137-97846B35-67F8-4705-9DA1-EED8DADACDDFQ33499069-7FB06AB2-C396-4F2F-846D-65086D29C6F2Q33501857-F688E7B0-D0B1-46F2-824C-F482F87EF609Q33502888-0B86708E-A570-444A-A363-1A3F8576A323Q33563548-22D9E8AE-F70A-4FA0-A86E-BD69993D806AQ33567341-EB2C59EA-AD89-47A5-919A-22A322411D8DQ33584053-3CD864D5-5238-4FCA-B81F-E4D240B21230Q33621131-A25A5067-84A0-4B69-BFAA-915BE6135D27Q33749895-E5325592-E213-4FA8-8122-30526292468FQ33766242-A596E4F7-6BBD-43A6-92F0-FC8553BBC406Q33915424-B554C96E-AA09-46E1-9158-81795EF047F4Q33915430-4C05FFDA-19E6-452A-B4A2-09A69BB587E3Q34158891-C35D8B50-82D5-4D12-B3E1-60C6E2FB5707Q34309757-554CDE9D-2C69-4ACE-A9B0-3D308102A44CQ34424638-17A7D30D-A442-4F81-ACE6-E534E2F9F2D4Q35082426-6953C55C-BDEF-4AFD-9248-1C55B637C2FAQ35195820-113C98CC-9FE9-4A6D-9918-30675197B105Q35208185-DC8CB104-E6AA-4904-A2AC-ECAFADF7F40DQ35310917-12A9CC88-ED1C-422D-BA68-EBD0DE550186
P2860
Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Prognosis in systemic lupus er ...... a, as well as causes of death.
@ast
Prognosis in systemic lupus er ...... a, as well as causes of death.
@en
type
label
Prognosis in systemic lupus er ...... a, as well as causes of death.
@ast
Prognosis in systemic lupus er ...... a, as well as causes of death.
@en
prefLabel
Prognosis in systemic lupus er ...... a, as well as causes of death.
@ast
Prognosis in systemic lupus er ...... a, as well as causes of death.
@en
P356
P1476
Prognosis in systemic lupus er ...... a, as well as causes of death.
@en
P2093
Alarcón GS
Bartolucci A
P356
10.1002/ART.1780330105
P577
1990-01-01T00:00:00Z